We are live on ! Find out more
PS

Peter Svennilson Portfolio holdings

AUM $1.23B
1-Year Est. Return 301.34%
This Fund
S&P 500
This Quarter Est. Return
+153.47%
1 Year Est. Return
+301.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$188M
AUM Growth
+$74.3M
Cap. Flow
+$9
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$9

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$63.4M 33.76%
4,677,939
+1
+0% +$9
RCUS icon
2
Arcus Biosciences
RCUS
$3.55B
$44.2M 23.56%
3,540,850
– –
GRTS
3
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$41.3M 21.98%
3,102,934
– –
IMDZ
4
DELISTED
Immune Design Corp.
IMDZ
$38.9M 20.7%
6,642,942
– –

Similar funds

CT
CGM Trust Boston, Massachusetts $957M AUM
CAW
Cornerstone Advisors (Washington) Bellevue, Washington $936M AUM 8.77% 1-Year Est. Return
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
SFSG
Stearns Financial Services Group Greensboro, North Carolina $639M AUM 11.66% 1-Year Est. Return
KFA
Kays Financial Advisory Atlanta, Georgia $624M AUM 9.93% 1-Year Est. Return
11A
10-15 Associates Goshen, New York $516M AUM 7.62% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return

Peter Svennilson's Q1 2019 Portfolio in Review

As of Q1 2019, Peter Svennilson held 4 positions worth $188M, up 65% from $113M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 0%. Peter Svennilson opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 92% a quarter earlier.

  • Peter Svennilson added most to Constellation Pharmaceuticals, Inc. in Q1 2019, an estimated $9 increase.
  • Peter Svennilson's ten largest holdings make up 100% of its $188M portfolio in Q1 2019.
  • Peter Svennilson opened 0 new positions and closed 0 in Q1 2019.
  • Peter Svennilson's portfolio value rose 65% quarter-over-quarter to $188M.

Based on Peter Svennilson's 13F filing for Q1 2019, filed 8 May 2019.